baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

BVT Knock-Out ABBV/ DE000VM6U8V4 /

2024-06-18 9:37:38 PM	Chg.+0.17	Bid10:00:38 PM	Ask10:00:38 PM	Underlying	Strike price	Expiration date	Option type
1.76EUR	+10.69%	- Bid Size: -	- Ask Size: -	AbbVie Inc	153.20 USD	2078-12-31	Call

GlobeNewswire 2:00 PM CytomX Therapeutics to Present at the H.C. Wainwright 2nd Annual Immune Cell Engager Virtual Confere...

GlobeNewswire 12:13 PM CEREVEL STOCK UPDATE: Is $45 Per Share Enough for Cerevel (Nasdaq:CERE)? Contact BFA Law about Ongoi...

GlobeNewswire 06-17 CytomX Therapeutics Promotes Chris Ogden to Chief Financial Officer

GlobeNewswire 06-17 Autonomix Enhances Executive Leadership Team with Appointment of Proven Medical Technology Leader, B...

GlobeNewswire 06-15 CEREVEL STOCK NOTICE: Think $45 Per Share is Too Low for Cerevel (Nasdaq: CERE)? Contact BFA Law abo...

Newsfile Corp 06-13 BioMed X Launches New US Institute in New Haven, CT

GlobeNewswire 06-13 Anima Biotech to Present at the Society for Medicines Research’s Modulating RNA with Oligonucleotide...

GlobeNewswire 06-13 LifeSci Advisors Announces Appointment of Chris Howerton Ph.D.

GlobeNewswire 06-13 CEREVEL SHAREHOLDER REMINDER: Is $45 Per Share Enough for Cerevel (Nasdaq: CERE)? BFA Law is Investi...

GlobeNewswire 06-13 What Employees at the Fortune Best Workplaces in New York, Chicago, Texas, and the Bay Area Value Mo...

GlobeNewswire 06-12 US Gastroenterologists Express Anticipation for Approval of AbbVie’s Skyrizi in Ulcerative Colitis, ...

GlobeNewswire 06-12 OSE Immunotherapeutics KOL Investor Webinar on the Therapeutic Landscape and Unmet Medical Needs in ...

GlobeNewswire 06-11 CEREVEL ALERT: Is $45 Per Share Too Low for Cerevel (Nasdaq: CERE)? BFA Law is Investigating and Urg...

GlobeNewswire 06-08 CEREVEL NEWS NOTIFICATION: BFA Law Alerts Cerevel (Nasdaq: CERE) Shareholders of Investigation into ...

GlobeNewswire 06-05 CEREVEL INVESTIGATION ALERT: Cerevel (Nasdaq: CERE) Investors are Encouraged to Contact BFA Law abou...

GlobeNewswire 06-05 Coherus BioSciences Appoints Rita Karachun, CPA, CGMA to its Board of Directors

GlobeNewswire 06-05 OSE Immunotherapeutics and Nantes University Hospital Present Positive Phase 1/2 Study Evaluating FR...

GlobeNewswire 06-04 Royalty Pharma to Present at the Goldman Sachs 45th Annual Global Healthcare Conference

GlobeNewswire 06-04 BioVie Announces Formation of Advisory Board for Bezisterim in Long COVID

GlobeNewswire 06-03 Royalty Pharma Announces Pricing of $1.5 Billion of Senior Unsecured Notes

GlobeNewswire 06-03 ACQUISITION NEWS: Cerevel’s (Nasdaq: CERE) $45 Merger Offer is Being Investigated for Being Too Low,...

GlobeNewswire 06-01 CERE (NASDAQ) REMINDER: BFA Law Reminds Cerevel Shareholders to Inquire About Ongoing Investigation ...

GlobeNewswire 05-30 OSE Immunotherapeutics Provides Business and Corporate Update

GlobeNewswire 05-29 Lynch Carpenter Investigates Claims in Cencora, Inc. Data Breach

GlobeNewswire 05-28 Sight Sciences Announces the Publication of Twelve-Month Results of the SAHARA RCT Demonstrating Imp...

BVT Knock-Out ABBV/ DE000VM6U8V4 /

If you wish to receive reply to your feedback, please provide your email address.